| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba3f70d4bcad1958ae8868ddab079b8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_095fc4a13daf2773d72648d379b28b7d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate |
2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdd65bf4aacb33e80df6d3684cde2e01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a51909ec8c52f2068271fca3185074d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ed6660a3cc5f3360058aff54a665554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c663a28491d66f6e038b534b1bbb810 |
| publicationDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2651515-T3 |
| titleOfInvention |
The miRNA-212/132 family as a therapeutic target |
| abstract |
A miR-132 inhibitor for use in the treatment or prevention of cardiac hypertrophy, autophagic disorders or associated with cardiac hypertrophy, and / or cardiac dysfunction, in which the inhibitor is an isolated nucleic acid molecule that have sufficient complementarity with miR -132 to form a hybrid under physiological conditions. |
| priorityDate |
2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |